Home
Products
Learn
About
Pricing
Log In
CUV
Asset Logo

Clinuvel Pharmaceuticals Limited

🇦🇺 ASX

🧬 BIOTECHNOLOGY

Compare
Add to watchlist
👑 Overview

📈 Performance

💰 Dividends

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-9.10%
Annual Growth

5 years average annual capital growth

💰

0.34%
Annual dividend yield

Based on the most recent dividend

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

20
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-02-13. The firm is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).

📈 Performance

Price History

+282.29%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💰 Dividends

Payouts

💰 Annual Dividend Yield*

0.34%

💰 Annual Dividend Earnings Per $1,000 invested**

$3.37

💰 Most Recent Dividend Franked Percentage Estimate

100.00%

💰 Average Dividend Franked Percentage Estimate

100.00 %

💰 Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of CUV, your last dividend payment(s) would have been:

$ 47.02

on Fri Sep 20 2024

$ 39.35

on Wed Sep 20 2023

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2025

$0.00

0.00%

2024

$0.00

0.00%

2023

$0.05

Infinity%

2022

$0.04

Infinity%

2021

$0.03

Infinity%

2020

$0.03

NaN%

2019

$0.03

NaN%

2018

$0.02

0.00%

2017

$0.00

0.00%

2016

$0.00

0.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🍃 Environmental, Social and Governance scores ℹ️

🌳

Environmental Score
3

A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution

🕊️

Social Score
64

An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.

⚖️

Governance Score
50

An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.

🤓 Advanced information

Technical Info

💰 Price*

$11.01

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in CUV

20

📊 Total Capital Earnings

$8K

🔃 Average investment frequency

17 weeks

💵 Average investment amount

$6,338

Last time a customer invested in CUV

1 day
CUV investor breakdown
💵 Income of investors

More than 200k

150k - 200k

17%

100k - 150k

7%

50k - 100k

34%

Less than 50k

38%
👶 Age of investors

18 - 25

26 - 34

20%

35 - 90

70%
🙋 Legal gender of investors

Female

Male

90%

Pearlers who invest in CUV also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

9.69%

📊 Share price

$98.63 AUD

🇦🇺 AUSTRALIA

🧱 MATERIALS

💸 FINANCIALS

⛳️ DIVERSIFIED

📈 HIGH PRICE GROWTH

Find Out More

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 9,980 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

🙌 Performance (5Yr p.a)

8.99%

📊 Share price

$36.08 AUD

🕊️ SOCIALLY AWARE

🌳 ENVIRONMENTAL

🩺 HEALTH CARE

Pilbara Minerals Ltd. engages in the provision of exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm owns 100% of an independent hard-rock lithium operation, the Pilgangoora operation in Australia, and the Colina Project in Brazil. Its Pilgangoora operation is located 140 kilometers (kms) from Port Hedland in Western Australia’s resource rich Pilbara region on Nyamal and Kariyarra Country. Spodumene concentrate from its Pilgangoora operation is shipped from Port Hedland, the bulk export port, to lithium chemical converters primarily in China. The firm's Colina project is located 10 kms from the town of Salinas in the world class mining jurisdiction of Minas Gerais, Brazil. The firm is also integrated into the lithium value chain through its joint venture with POSCO in South Korea, which manufactures battery-grade lithium hydroxide.

🙌 Performance (5Yr p.a)

143.49%

📊 Share price

$1.49 AUD

⛏️ MINING

Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. The company is headquartered in Sydney, New South Wales and currently employs 42,000 full-time employees. The firm is engaged in laboratory medicine / pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America. The firm operates through three segments: Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Radiology technologies include Magnetic resonance imaging (MRI), Computed tomography (CT), Ultrasound, X-ray, Mammography, and others. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. The firm's provides services to clinicians, hospitals, community health services, and their patients. The firm has more than 120 radiology centers.

🙌 Performance (5Yr p.a)

0.83%

📊 Share price

$25.50 AUD

🕊️ SOCIALLY AWARE

🩺 HEALTH CARE

🌳 ENVIRONMENTAL

Goodman Group operates as a provider of essential infrastructure. The company is headquartered in Rosebery, New South Wales and currently employs 976 full-time employees. The company went IPO on 2005-02-02. The firm owns, develops and manages high-quality, sustainable logistics properties and data centers in major global cities that are critical to the digital economy. Its operating segments are Australia and New Zealand, Asia (Greater China (including the Hong Kong SAR) and Japan), Continental Europe (with assets located in Germany, France, Spain and the Netherlands), the United Kingdom and the Americas (principally North America and including Brazil). The firm comprises the stapled entities Goodman Limited, Goodman Industrial Trust and Goodman Logistics (HK) Limited. Its property portfolio includes logistics and distribution centers, warehouses, light industrial, multi-story industrial, business parks and data centers. The company takes a long-term view, investing significantly alongside its capital partners in its investment management platform and concentrating on the portfolio where it can create value for customers and investors.

🙌 Performance (5Yr p.a)

24.39%

📊 Share price

$28.74 AUD

📈 HIGH PRICE GROWTH

🏠 REAL ESTATE

🕊️ SOCIALLY AWARE

Want more shares? Try these...

CUX

📊 Share price

$0.02 AUD
Compare
Add to watchlist